Paths of Progress
Immune system cells (in yellow> swarm in for an attack on a cancer cell.
Fall/Winter 2002
Volume 11, Number 2
Contents
Features
- Attacking tumors from within Dana-Farber researchers are developing vaccines that use the body's own disease-fighting forces as a weapon against tumors. They're doing so by devising ways to make cancerous cells more conspicuous to the immune system.
- Saying 'You're cured' is not enough
At a time when more children are surviving brain tumors, the Institute is exploring the long-term effects of treatments and ways to help young survivors cope with their complications, both at home and in school. - One doctor, many roles
As a clinician, researcher, colleague, mentor, and leader in the field of genitourinary oncology, Philip Kantoff, MD, represents the "bench-to-bedside" model pioneered by Institute founder Sidney Farber, MD. - Beyond the breakthroughs
Senior Vice President for Experimental Medicine Lee Nadler, MD, discusses the challenge of converting laboratory findings to treatments and plans for advancing Dana-Farber's success in this arena. - Patients and families make a difference
Dana-Farber is considered a national leader in efforts to give patients and families a strong voice in decision making about their care.
Departments
- Dateline DFCI
Recent Institute news, including a successful accreditation visit and a new mammography van and hospice program. - Discoveries
Dana-Farber's latest research findings. - First Person
Boston Red Sox President and CEO Larry Lucchino reflects on baseball, bone marrow transplants, and giving back in this conversation with Saul Wisnia. - A Letter from the President
Credits
President, Dana-Farber Cancer Institute Edward J. Benz Jr., MD
Chief of Staff Stephen E. Sallan, MD
Chief Medical Officer Lawrence Shulman, MD
Chair, Medical Oncology James Griffin, MD
Chair, Pediatric Oncology Stuart H. Orkin, MD
Chair, Executive Committee for Research Stanley J. Korsmeyer, MD
Senior Vice President for Experimental Medicine Lee M. Nadler, MD
Senior Vice President for Communications Steven R. Singer
Director of Publications Paul Hennessy
Editor Debra Ruder
Associate Editor Saul Wisnia
Staff Writers Robert Levy, Richard Saltus
Design John DiGianni
Production Assistance Hilary Bennett, Christine Cleary, Kristin Lacey
Photography C.J. Allen, Eric Antoniou, The Brearley Collection, Lisa Cohen, Steve Gilbert,
Shawn Henry, Bill Horsman, Justin Allardyce Knight, Carol Lundeen, Matt McKee, Mark Ostow, Caroline Woodcheke
Paths of Progress is published twice a year by Dana-Farber Cancer Institute's Department of Communications. Address correspondence to:
Debra Ruder, Editor
Paths of Progress
debra_ruder@dfci.harvard.edu
Dana-Farber Cancer Institute
Department of Communications
375 Longwood Ave.
Boston, MA 02215-5347
or call (617) 632-4090
Copyright © 2002 Dana-Farber Cancer Institute. All rights reserved.
